Clobetasol reduces vulvar malignancy risk at 2 years after diagnosis; topical calcineurin inhibitors do not increase malignancy risk.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/clobetasol-reduces-early-vulvar-malignancy-risk-lichen-2026a1000dgx?src=rss
Author :
Publish date : 2026-04-28 10:36:00
Copyright for syndicated content belongs to the linked Source.